{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:17:04Z","timestamp":1787008624543,"version":"build-2736575974"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["award number HPC-1503-28122"],"award-info":[{"award-number":["award number HPC-1503-28122"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015627","name":"Quest Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015627","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Monogram Biosciences"},{"name":"OraSure Technologies"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatitis C virus (HCV) is a leading cause of infectious disease death in the United States. Although highly effective direct-acting antiviral (DAA) regimens are well established, retreatment among people who inject drugs (PWID) has not been sufficiently studied. This study assessed DAA retreatment outcomes and associated factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed analyses of longitudinal data from the HERO Study, a US-based multi-site pragmatic randomized trial conducted in 8 states to evaluate effectiveness of 2 HCV care models among DAA treatment-na\u00efve PWID in opioid treatment programs and community clinics. After initial HERO Study sofosbuvir\/velpatasvir (SOF\/VEL) treatment, participants eligible for retreatment were identified, from 15 September 2016 to 13 September 2021. This analysis characterizes participants who either did not achieve sustained virologic response (SVR) or were reinfected with HCV post-SVR. We compared categorical variables using Fisher exact test and continuous variables using the Welch 2 sample t test for means and an asymptotic 2-sample Mood median test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred four participants were identified as eligible for retreatment. Less than half, 43 (41.3%), initiated retreatment. Among the 25 who initiated retreatment and for whom SVR results were available, 24 achieved SVR (96%). Participants who did not achieve SVR initiated retreatment more promptly than participants reinfected post-SVR (respectively, 471 vs 784 days on average, P &amp;lt; .001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>After reinfection or not achieving SVR with the first DAA regimen, retreated PWID achieved higher SVR rates than with initial DAA treatment. To attain HCV elimination and benefit individual and public health, assisting PWID with accessing prompt retreatment is crucial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf082","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T16:22:47Z","timestamp":1743351767000},"page":"923-930","source":"Crossref","is-referenced-by-count":4,"title":["Retreatment of Hepatitis C Virus Among People Who Inject Drugs"],"prefix":"10.1093","volume":"81","author":[{"given":"Aurielle M","family":"Thomas","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice and Clinical Research, University of Rhode Island , Kingston, Rhode Island ,","place":["USA"]},{"name":"Division of Infectious Diseases, The Miriam Hospital , Providence, Rhode Island ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6717-0288","authenticated-orcid":false,"given":"Alain H","family":"Litwin","sequence":"additional","affiliation":[{"name":"Department of Medicine at Prisma Health, Clemson University School of Health Research , Clemson, South Carolina ,","place":["USA"]},{"name":"Department of Medicine, University of South Carolina School of Medicine , Greenville, South Carolina ,","place":["USA"]},{"name":"Department of Medicine, Prisma Health , Greenville, South Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0877-5399","authenticated-orcid":false,"given":"Judith I","family":"Tsui","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Washington , Seattle, Washington ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0023-1592","authenticated-orcid":false,"given":"Sophie","family":"Sprecht-Walsh","sequence":"additional","affiliation":[{"name":"CODAC Behavioral Health , Providence, Rhode Island ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra L","family":"Blalock","sequence":"additional","affiliation":[{"name":"Comangine Health, Data Solutions , Seattle, Washington ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1211-3120","authenticated-orcid":false,"given":"Karen T","family":"Tashima","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brown University , Providence, Rhode Island ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J","family":"Lum","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4206-7214","authenticated-orcid":false,"given":"Judith","family":"Feinberg","sequence":"additional","affiliation":[{"name":"Department of Behavioral Medicine & Psychiatry and Department of Medicine, Infectious Diseases, West Virginia University School of Medicine , Morgantown, West Virginia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7120-1673","authenticated-orcid":false,"given":"Kimberly","family":"Page","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of New Mexico Health Sciences Center , Albuquerque, New Mexico ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2523-0959","authenticated-orcid":false,"given":"Shruti H","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Y","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8287-2245","authenticated-orcid":false,"given":"Brianna L","family":"Norton","sequence":"additional","affiliation":[{"name":"Department of Medicine, Montefiore Medical Center\/Albert Einstein College of Medicine , Bronx, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7711-1209","authenticated-orcid":false,"given":"Moonseong","family":"Heo","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Clemson University , Clemson, South Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen S","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5488-1080","authenticated-orcid":false,"given":"Cristina","family":"Murray-Krezan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7741-1567","authenticated-orcid":false,"given":"Julia","family":"Arnsten","sequence":"additional","affiliation":[{"name":"Department of Medicine, Montefiore Medical Center\/Albert Einstein College of Medicine , Bronx, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4869-6235","authenticated-orcid":false,"given":"Megan","family":"Groome","sequence":"additional","affiliation":[{"name":"Department of Medicine, Prisma Health , Greenville, South Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Waters","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of South Carolina School of Medicine , Greenville, South Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0472-8125","authenticated-orcid":false,"given":"Lynn E","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Clinical Research, University of Rhode Island , Kingston, Rhode Island ,","place":["USA"]},{"name":"Department of Medicine, HealthFirst Family Care Center Inc. , Fall River, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"2025122403230698900_ciaf082-B1","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Global Health"},{"key":"2025122403230698900_ciaf082-B2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/HEP.0000000000000927","article-title":"Estimating hepatitis C prevalence in the United States, 2017\u20132020","volume":"81","author":"Hall","year":"2024","journal-title":"Hepatology"},{"key":"2025122403230698900_ciaf082-B3","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/cid\/ciw111","article-title":"Rising mortality associated with hepatitis C virus in the United States, 2003\u20132013","volume":"62","author":"Ly","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025122403230698900_ciaf082-B4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.15585\/mmwr.mm7226a3","article-title":"Hepatitis C virus clearance cascade\u2014United States, 2013\u20132022","volume":"72","author":"Wester","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025122403230698900_ciaf082-B5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hep.32347","article-title":"Machine learning algorithms for predicting direct-acting antiviral treatment failure in chronic hepatitis C: an HCV-TARGET analysis","volume":"76","author":"Park","year":"2022","journal-title":"Hepatology"},{"key":"2025122403230698900_ciaf082-B6","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.7326\/M21-4119","article-title":"Reinfection and risk behaviors after treatment of hepatitis C virus infection in persons receiving opioid agonist therapy: a cohort study","volume":"175","author":"Grebely","year":"2022","journal-title":"Ann Intern Med"},{"key":"2025122403230698900_ciaf082-B7","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir, Velpatasvir, and Voxilaprevir for previously treated HCV infection","volume":"376","author":"Bourliere","year":"2017","journal-title":"N Engl J Med"},{"key":"2025122403230698900_ciaf082-B8","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2019.06.002","article-title":"Effectiveness and safety of sofosbuvir\/velpatasvir\/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs","volume":"71","author":"Llaneras","year":"2019","journal-title":"J Hepatol"},{"key":"2025122403230698900_ciaf082-B9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/jvh.13705","article-title":"Retreatment for hepatitis C virus direct acting antiviral therapy virological failure in primary and tertiary settings: the REACH-C cohort","volume":"29","author":"Carson","year":"2022","journal-title":"J Viral Hepat"},{"key":"2025122403230698900_ciaf082-B10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jhep.2022.09.011","article-title":"National trends in retreatment of HCV due to reinfection or treatment failure in Australia","volume":"78","author":"Carson","year":"2023","journal-title":"J Hepatol"},{"key":"2025122403230698900_ciaf082-B11","author":"World Health Organization"},{"key":"2025122403230698900_ciaf082-B12","author":"US Department of Health and Human Services"},{"key":"2025122403230698900_ciaf082-B13"},{"key":"2025122403230698900_ciaf082-B14"},{"key":"2025122403230698900_ciaf082-B15","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S2468-1253(22)00275-8","article-title":"Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial","volume":"7","author":"Litwin","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025122403230698900_ciaf082-B16","doi-asserted-by":"crossref","first-page":"105859","DOI":"10.1016\/j.cct.2019.105859","article-title":"Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: the HERO study","volume":"87","author":"Litwin","year":"2019","journal-title":"Contemp Clin Trials"},{"key":"2025122403230698900_ciaf082-B17","author":"RStudio Team"},{"key":"2025122403230698900_ciaf082-B18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/jvh.13549","article-title":"Real world SOF\/VEL\/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy","volume":"28","author":"Smith","year":"2021","journal-title":"J Viral Hepat"},{"key":"2025122403230698900_ciaf082-B19","doi-asserted-by":"crossref","first-page":"e799","DOI":"10.1093\/cid\/ciaa1510","article-title":"Salvage therapy with sofosbuvir\/velpatasvir\/voxilaprevir in DAA-experienced patients: results from a prospective Canadian registry","volume":"72","author":"Onofrio","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf082\/62928007\/ciaf082.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/5\/923\/62928007\/ciaf082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/5\/923\/62928007\/ciaf082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:23:16Z","timestamp":1766564596000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/81\/5\/923\/8113365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,15]]},"published-print":{"date-parts":[[2025,12,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf082","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,15]]},"published":{"date-parts":[[2025,4,15]]}}}